Table 2.
Outcome | Total (N=27) | 1500 mg (N=12) | 3000 mg (N=15) |
---|---|---|---|
Death | 0 | 0 | 0 |
Left ventricular assist device | 1 | 1 | 0 |
Heart transplant | 0 | 0 | 0 |
Serious adverse events* | 2 | 1 | 1 |
All cause hospitalizations | |||
Total N of hospitalizations | 24 | 8 | 16† |
Patients with hospitalizations | 9 | 5 | 4 |
Cardiovascular hospitalizations | |||
Total N of CV hospitalizations | 20 | 7 | 13 † |
Patients with CV hospitalizations | 9 | 5 | 4 |
Heart failure (HF) hospitalizations | |||
Total N of HF hospitalizations | 9 | 2 | 7 † |
Patients with HF hospitalizations | 4 | 1 | 3 |
Systolic blood pressure drop <90 mmHg in the 1500mg arm and creatine increase >0.5 mg/dL in the 3000-mg arm
1 patient had 10 encounters; 8 for cardiovascular reasons and 4 specifically for heart failure